Frances Arnold, Director at Generate Biomedicines, Inc. (GENB), sold 1,000 shares at $16.00 ($16K) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($16k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GOOGL | SELL | 2026-07-30 | $27K | — | Filing → |
| GOOGL | SELL | 2026-06-30 | $39K | — | Filing → |
| GOOGL | SELL | 2026-06-01 | $39K | — | Filing → |